Aziyo Biologics, Inc. - AZYO

About Gravity Analytica
Recent News
- 03.06.2025 - Elutia Q4 2024 Financial Results Call
- 03.06.2025 - Elutia Announces Fourth Quarter and Full Year 2024 Financial Results: Strong Demand for EluPro™ in Pilot Launch Sets the Stage for Full Commercial Roll-Out
- 03.06.2025 - Elutia Announces Fourth Quarter and Full Year 2024 Financial Results: Strong Demand for EluPro™ in Pilot Launch Sets the Stage for Full Commercial Roll-Out
- 02.20.2025 - Elutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025
- 02.20.2025 - Elutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025
- 02.03.2025 - Elutia Announces $15.0 Million Registered Direct Offering
- 02.03.2025 - Elutia Announces $15.0 Million Registered Direct Offering
- 01.14.2025 - Elutia Announces Full Launch of EluPro™ Following Strong Initial Demand
- 01.14.2025 - Elutia Announces Full Launch of EluPro™ Following Strong Initial Demand
- 01.06.2025 - Elutia Announces EluPro™ GPO Agreement with Southern Strategic Sourcing Partners
Recent Filings
- 03.06.2025 - 8-K Current report
- 03.06.2025 - EX-99.1 EX-99.1
- 02.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 02.04.2025 - EX-99.1 EX-99.1
- 02.04.2025 - 8-K Current report
- 02.03.2025 - 8-K Current report
- 02.03.2025 - 424B5 Prospectus [Rule 424(b)(5)]
- 01.29.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 12.11.2024 - 4 Statement of changes in beneficial ownership of securities